• 1
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 2
    Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 134653.
  • 3
    Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 1999; 42: 222030.
  • 4
    Fries JF, et al. The Arthritis, Rheumatism, and Aging Medical Information System. Aramis: HAQ. URL:
  • 5
    Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 2004; 50: 3296305.
  • 6
    De Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36: 87883.
  • 7
    Wolfe F, Michaud K, Pincus T. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis. J Rheumatol 2005; 32: 12616.
  • 8
    Fries JF, Cella D, Rose M, Krishnan E, Bruce B. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 2009; 36: 20616.
  • 9
    Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003; 1: 20.
  • 10
    Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: a community-based study. Med Care 1993; 31: 26976.
  • 11
    Gillen M. Injuries from construction falls: functional limitations and return to work. AAOHN J 1999; 47: 6573.
  • 12
    Carreno A, Fernandez I, Badia X, Varela C, Roset M. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. Value Health 2011; 14: 192200.
  • 13
    Wolfe F, Michaud K, Wallenstein G. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis. J Rheumatol 2010; 37: 161525.
  • 14
    Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, et al. Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 2010; 32: 132942.
  • 15
    Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, et al. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 96371.
  • 16
    Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005; 60: 157182.
  • 17
    Kobelt G, Lindgren P, Lindroth Y, Jacobson L, Eberhardt K. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 116975.
  • 18
    Kobelt G, Jonsson L, Young A, Eberhardt K. The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study. Rheumatology (Oxford) 2003; 42: 32635.
  • 19
    Tomlin GS, Holm MB, Rogers JC, Kwoh CK. Comparison of standard and alternative health assessment questionnaire scoring procedures for documenting functional outcomes in patients with rheumatoid arthritis. J Rheumatol 1996; 23: 152430.
  • 20
    Yazici Y, Bergman M, Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol 2008; 35: 6039.
  • 21
    McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press; 1996. p. 10615.
  • 22
    Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D (corrected) RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008; 35: 152837.
  • 23
    Daltroy LH, Larson MG, Eaton HM, Phillips CB, Liang MH. Discrepancies between self-reported and observed physical function in the elderly: the influence of response shift and other factors. Soc Sci Med 1999; 48: 154961.
  • 24
    Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000; 43: 275161.
  • 25
    Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003; 30: 16778.
  • 26
    Sousa KH, Kwok OM, Ryu E, Cook SW. Confirmation of the validity of the HAQ-DI in two populations living with chronic illnesses. J Nurs Meas 2008; 16: 3142.
  • 27
    Cole JC, Motivala SJ, Khanna D, Lee JY, Paulus HE, Irwin MR. Validation of single-factor structure and scoring protocol for the Health Assessment Questionnaire-Disability Index. Arthritis Rheum 2005; 53: 53642.
  • 28
    Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 210817.
  • 29
    Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 153042.
  • 30
    Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993; 20: 55760.
  • 31
    Pope JE, Khanna D, Norrie D, Ouimet JM. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009; 36: 2549.
  • 32
    Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000; 43: 147887.
  • 33
    Wolfe F, Michaud K, Strand V. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences: analyses in 8,931 patients with rheumatoid arthritis. J Rheumatol 2005; 32: 5839.
  • 34
    Stucki G, Stucki S, Bruhlmann P, Michel BA. Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients. Ann Rheum Dis 1995; 54: 4615.
  • 35
    Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001; 28: 9829.
  • 36
    Ackerman IN, Graves SE, Bennell KL, Osborne RH. Evaluating quality of life in hip and knee replacement: psychometric properties of the World Health Organization Quality of Life short version instrument. Arthritis Rheum 2006; 55: 58390.
  • 37
    Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999; 42: 1797808.
  • 38
    Wolfe F. The psychometrics of functional status questionnaires: room for improvement. J Rheumatol 2002; 29: 8658.
  • 39
    Anderson J, Sayles H, Curtis JR, Wolfe F, Michaud K. Converting modified health assessment questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2010; 62: 14818.
  • 40
    Martin M, Kosinski M, Bjorner JB, Ware JE Jr, Maclean R, Li T. Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale. Qual Life Res 2007; 16: 64760.
  • 41
    Calvo-Alen J, Corrales A, Sanchez-Andrada S, Fernandez-Echevarria MA, Pena JL, Rodriguez-Valverde V. Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort. Clin Rheumatol 2003; 22: 7783.
  • 42
    Hewlett S, Smith AP, Kirwan JR. Values for function in rheumatoid arthritis: patients, professionals, and public. Ann Rheum Dis 2001; 60: 92833.
  • 43
    Callahan LF, Pincus T, Huston JW 3rd, Brooks RH, Nance EP Jr, Kaye JJ. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997; 10: 38194.
  • 44
    Ziebland S, Fitzpatrick R, Jenkinson C, Mowat A, Mowat A. Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ. Ann Rheum Dis 1992; 51: 12025.
  • 45
    Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, et al, on behalf of the Leflunomide Rheumatoid Arthritis Investigators Group. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Arthritis Rheum 2000; 43: 50614.
  • 46
    Serrano MA, Beltran Fabregat J, Olmedo Garzon J. Should the MHAQ ever be used? [letter]. Ann Rheum Dis 1996; 55: 2712.
  • 47
    Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O. The incidence and severity of rheumatoid arthritis: results from a county register in Oslo, Norway. J Rheumatol 1998; 25: 107884.
  • 48
    Pincus T, Yazici Y, Bergman M. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol 2007; 21: 75587.
  • 49
    Lee SS, Park MJ, Yoon HJ, Park YW, Park IH, Park KS. Evaluating the Korean version of the Multidimensional Health Assessment Questionnaire in patients with rheumatoid arthritis. Clin Rheumatol 2006; 25: 3537.
  • 50
    Arkela-Kautiainen M, Kautiainen H, Uutela T, Laiho K, Blafield H, Leirisalo-Repo M, et al. Evaluation of the MDHAQ in Finnish patients with RA (corrected). J Rheumatol 2005; 32: 142631.
  • 51
    Kumar A, Malaviya AN, Pandhi A, Singh R. Validation of an Indian version of the Health Assessment Questionnaire in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 14579.
  • 52
    Doventas A, Karadag B, Curgunlu A, Bilici A, Sut N, Erdincler DS, et al. Replicability and reliability of pain assessment forms in geriatrics. Arch Gerontol Geriatr 2010. E-pub ahead of print.
  • 53
    Sullivan MB, Iannaccone C, Cui J, Lu B, Batra K, Weinblatt M, et al. Evaluation of selected rheumatoid arthritis activity scores for office-based assessment. J Rheumatol 2010; 37: 24668.
  • 54
    Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol 2004; 31: 17236.
  • 55
    Pincus T, Keysor J, Sokka T, Krishnan E, Callahan LF. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1,416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 2004; 31: 22934.
  • 56
    Blanchais A, Berthelot JM, Fontenoy AM, le Goff B, Maugars Y. Weekly home self-assessment of RAPID-4/3 scores in rheumatoid arthritis: a 6-month study in 26 patients. Joint Bone Spine 2010; 77: 5827.
  • 57
    Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ (corrected) for standard care of patients with rheumatic diseases. J Rheumatol 2005; 32: 14329.
  • 58
    Ten Klooster PM, Taal E, van de Laar MA. Rasch analysis of the Dutch health assessment questionnaire disability index and the health assessment questionnaire II in patients with rheumatoid arthritis. Arthritis Rheum 2008; 59: 17218.
  • 59
    Wolfe F. Why the HAQ-II can be an effective substitute for the HAQ. Clin Exp Rheumatol 2005; 23 Suppl 39: S2930.
  • 60
    Lillegraven S, Kvien TK. Measuring disability and quality of life in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 82740.
  • 61
    Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997; 36: 8848.
  • 62
    Kutlay S, Kucukdeveci AA, Gonul D, Tennant A. Adaptation and validation of the Turkish version of the Rheumatoid Arthritis Quality of Life Scale. Rheumatol Int 2003; 23: 216.
  • 63
    Neville C, Whalley D, McKenna S, Le Comte M, Fortin PR. Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada. J Rheumatol 2001; 28: 150510.
  • 64
    Eberhardt K, Duckberg S, Larsson BM, Johnson PM, Nived K. Measuring health related quality of life in patients with rheumatoid arthritis: reliability, validity, and responsiveness of a Swedish version of RAQoL. Scand J Rheumatol 2002; 31: 612.
  • 65
    Tammaru M, McKenna SP, Meads DM, Maimets K, Hansen E. Adaptation of the rheumatoid arthritis quality of life scale for Estonia. Rheumatol Int 2006; 26: 65562.
  • 66
    Cox SR, McWilliams L, Massy-Westropp N, Meads DM, McKenna SP, Proudman S. Adaptation of the RAQoL for use in Australia. Rheumatol Int 2007; 27: 6616.
  • 67
    Greenwood MC, Hakim AJ, Doyle DV. A simple extension to the Rheumatoid Arthritis Quality of Life Questionnaire (RAQoL) to explore individual patient concerns and monitor group outcome in clinical practice. Rheumatology (Oxford) 2006; 45: 615.
  • 68
    Inotai A, Rojkovich B, Fulop A, Jaszay E, Agh T, Meszaros A. Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatol Int 2011. E-pub ahead of print.
  • 69
    Tijhuis GJ, de Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LM, Hazes JM, et al. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford) 2001; 40: 11129.
  • 70
    Garip Y, Eser F, Bodur H. Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int 2010. E-pub ahead of print.
  • 71
    Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 2005; 14: 133344.
  • 72
    Pentek M, Szekanecz Z, Czirjak L, Poor G, Rojkovich B, Polgar A, et al. Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary. Orv Hetil 2008; 149: 73341. In Hungarian.
  • 73
    Raterman HG, Hoving JL, Nurmohamed MT, Herenius MM, Sluiter JK, Lems WF, et al. Work ability: a new outcome measure in rheumatoid arthritis? Scand J Rheumatol 2010; 39: 12731.